{"id":91439,"title":"[Sleep disorders and quality of life in refractory partial epilepsy: results of the SLEEP study].","abstract":"Alteraciones del sueño y calidad de vida en la epilepsia parcial refractaria: resultados del estudio SLEEP.Introduccion. Las alteraciones del sueño son frecuentes en pacientes con epilepsia y se correlacionan con una peor calidad de vida. Objetivos. Evaluar la prevalencia de las alteraciones del sueño en pacientes con epilepsia focal refractaria y no refractaria y explorar la influencia de estas alteraciones en la calidad de vida de los pacientes. Pacientes y metodos. Estudio epidemiologico, controlado, transversal, realizado en 150 consultas ambulatorias de neurologia. Se reclutaron pacientes que habian sido tratados con dos farmacos antiepilepticos desde el inicio de la enfermedad (18-55 años). Resultados. Se incluyeron 237 pacientes con epilepsia focal no refractaria y 264 pacientes con epilepsia focal refractaria. El 22% del grupo con epilepsia no refractaria y el 45% del grupo con epilepsia refractaria (p < 0,0001) padecian alguna altera­cion del sueño. Los pacientes con epilepsia refractaria tenian peor calidad de vida (p < 0,001) medida con el cuestionario de calidad de vida QOLIE-10. Se observo una correlacion positiva y significativa entre la calidad de vida y la calidad del sue­ño, tanto en el insomnio cronico (r = 0,65; p < 0,0001) como en la somnolencia excesiva diurna (r = 0,43; p < 0,0001). Conclusion. Las alteraciones del sueño son mas frecuentes en la epilepsia refractaria que en la no refractaria, y afectan a la calidad de vida de los pacientes.Sleep disorders are frequent among patients with epilepsy and are correlated with a poorer quality of life.To evaluate the prevalence of sleep disorders in patients with refractory and non-refractory focal epilepsy, and to explore the influence of these alterations on the quality of life of these patients.An epidemiological, controlled, cross-sectional study was conducted in 150 outpatient neurology services. Patients who had been treated with two antiepileptic drugs since the onset of the disease (18-55 years) were recruited for the study.The sample included 237 patients with non-refractory focal epilepsy and 264 patients with refractory focal epilepsy. Twenty-two per cent of the non-refractory epilepsy group and 45% of the group with refractory epilepsy (p < 0.0001) suffered from some sleep disorder. The patients with refractory epilepsy had a poorer quality of life (p < 0.001) as measured with the quality of life questionnaire QOLIE-10. A positive significant correlation was observed between quality of life and quality of sleep, in both chronic insomnia (r = 0.65; p < 0.0001) and excessive daytime sleepiness (r = 0.43; p < 0.0001).Sleep disorders are more frequent in refractory than in non-refractory epilepsy, and affect the patients' quality of life.","date":"2014-02-07","categories":"Wounds and Injuries","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24504877","annotations":[{"name":"Sleep disorder","weight":0.872009,"wikipedia_article":"http://en.wikipedia.org/wiki/Sleep_disorder"},{"name":"Epilepsy","weight":0.852356,"wikipedia_article":"http://en.wikipedia.org/wiki/Epilepsy"},{"name":"Insomnia","weight":0.821773,"wikipedia_article":"http://en.wikipedia.org/wiki/Insomnia"},{"name":"Quality of life","weight":0.816331,"wikipedia_article":"http://en.wikipedia.org/wiki/Quality_of_life"},{"name":"Neurology","weight":0.812569,"wikipedia_article":"http://en.wikipedia.org/wiki/Neurology"},{"name":"Anticonvulsant","weight":0.802861,"wikipedia_article":"http://en.wikipedia.org/wiki/Anticonvulsant"},{"name":"Somnolence","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Somnolence"},{"name":"Epidemiology","weight":0.787886,"wikipedia_article":"http://en.wikipedia.org/wiki/Epidemiology"},{"name":"Disease","weight":0.754651,"wikipedia_article":"http://en.wikipedia.org/wiki/Disease"},{"name":"Prevalence","weight":0.71741,"wikipedia_article":"http://en.wikipedia.org/wiki/Prevalence"},{"name":"Chronic (medicine)","weight":0.71741,"wikipedia_article":"http://en.wikipedia.org/wiki/Chronic_(medicine)"},{"name":"Sleep","weight":0.701843,"wikipedia_article":"http://en.wikipedia.org/wiki/Sleep"},{"name":"Drug","weight":0.648721,"wikipedia_article":"http://en.wikipedia.org/wiki/Drug"},{"name":"Excessive daytime sleepiness","weight":0.589333,"wikipedia_article":"http://en.wikipedia.org/wiki/Excessive_daytime_sleepiness"},{"name":"Disorder (medicine)","weight":0.552523,"wikipedia_article":"http://en.wikipedia.org/wiki/Disorder_(medicine)"},{"name":"Correlation and dependence","weight":0.209465,"wikipedia_article":"http://en.wikipedia.org/wiki/Correlation_and_dependence"},{"name":"Questionnaire","weight":0.133827,"wikipedia_article":"http://en.wikipedia.org/wiki/Questionnaire"},{"name":"Outpatient","weight":0.0595559,"wikipedia_article":"http://en.wikipedia.org/wiki/Outpatient"},{"name":"Functional group","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Functional_group"},{"name":"Confidence trick","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Confidence_trick"},{"name":"Absorption (pharmacokinetics)","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Absorption_(pharmacokinetics)"},{"name":"United States dollar","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/United_States_dollar"},{"name":"Selenium","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Selenium"},{"name":"Sampling (statistics)","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Sampling_(statistics)"}]}
